BioSpace News Archive

Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer

Polaris Biology, a leading innovator in single-cell technologies, announced the largest product launch in company history with the introduction of the Starion™ Mass Cytometry System.

October 23, 2021
·
1 min read
Drug Development

OncXerna Therapeutics Announces New Biomarker Data from Retrospective Analysis of Results from Phase 1b Ovarian Cancer Trial of Navicixizumab Plus Paclitaxel at the ESGO 2021 Congress

OncXerna Therapeutics, Inc. announced new biomarker data from a retrospective analysis of results from its Phase 1b clinical trial of navicixizumab in an electronic poster at the European Society of Gynaecological Oncology Congress 2021.

October 23, 2021
·
5 min read
Biotech Beach

Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatric and Young Adult Patients at SIOP 2021 Virtual Congress

Turning Point Therapeutics, Inc., a precision oncology company developing next-generation therapies that target genetic drivers of cancer, announced the presentation of early clinical data from the ongoing Phase 1/2 CARE study in pediatric and young adult patients with advanced solid tumors harboring ALK, ROS1 or NTRK alterations.

October 23, 2021
·
7 min read